“According to SNS Insider, the CMO/CDMO Market reached USD 23.32 billion in 2023 and is anticipated to grow up to USD 38.87 billion by 2032 at a compound annual growth rate of 5.86% during the forecast period 2024-2032.”
This is due to increasing pharmaceutical production complexity, rising demand for biologics and personalized medicine, and an overall trend toward outsourcing drug development and manufacturing.